Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
As assumptions underlying the forecast for the fiscal year ending March 2027 compared with the actual results for the fiscal year ended March 2026, the company expects a recovery from the impact of component supply shortages, continued demand for replacement of analog products with digital products and for crisis-management solutions, strong domestic products, and a reduced impact from U.S. tariff measures. At the same time, it anticipates delays in budget execution due to U.S. government shutdowns, as well as memory supply shortages and higher prices. No reason for revising the forecast from the previous forecast is stated.
Impairment loss of ¥701 million. A provision for losses related to the withdrawal from the healthcare business was also recorded, but the amount is not disclosed.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥364,000 million |
| Operating profit | Not disclosed → ¥20,600 million |
| Profit attributable to owners of the parent | Not disclosed → ¥15,000 million |
| Net income per share | Not disclosed → 106.13 yen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Fiscal year ended March 2026: revenue of ¥356,865 million, business profit of ¥20,880 million, operating profit of ¥20,540 million, profit before tax of ¥21,660 million, profit attributable to owners of the parent of ¥16,787 million, and basic earnings per share of ¥115.21 |
| Reason for the revision | As assumptions underlying the forecast for the fiscal year ending March 2027 compared with the actual results for the fiscal year ended March 2026, the company expects a recovery from the impact of component supply shortages, continued demand for replacement of analog products with digital products and for crisis-management solutions, strong domestic products, and a reduced impact from U.S. tariff measures. At the same time, it anticipates delays in budget execution due to U.S. government shutdowns, as well as memory supply shortages and higher prices. No reason for revising the forecast from the previous forecast is stated. |
| Details and amount of extraordinary loss | Impairment loss of ¥701 million. A provision for losses related to the withdrawal from the healthcare business was also recorded, but the amount is not disclosed. |
| Dividend forecast revision | For the fiscal year ending March 2027, the company forecasts an interim dividend of ¥10, a year-end dividend of ¥10, and an annual dividend of ¥20. The disclosure does not expressly state that this is a revision to the dividend forecast. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, revenue and profit declined due to lower production and sales caused by component supply shortages in the wireless systems business, as well as the impact of U.S. tariff measures on the mobility and telematics services and media businesses. For the fiscal year ending March 2027, the company expects a recovery from the impact of component supply shortages, continued demand, strong domestic products, and a reduced impact from tariff measures, while anticipating delays in budget execution due to U.S. government shutdowns and memory shortages and higher memory prices.